Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

General

AUD to go hungry as investors lose their appetite: Julius Baer

Global markets over the past few weeks have changed gears into more risk-averse positions and this could weaken the global appetite for the AUD.

Gold bull market set to continue: Baker Steel

The bull market for gold is moving to a new level while gold is actually the best performing currency.

Share traders switch to derivatives

A new derivative called Contracts for Difference (CFD) has drawn share traders in a big way according to a recent industry report.

Market Wrap

The Australian share market is expected to open sharply weaker as US markets surrendered the gains made yesterday, gold and oil prices continued to retreat and base metal prices pulled back from record highs.

Market Wrap

AAP  |  THURSDAY, 20 OCT 2005
The Australian share market is expected to open firmer after a positive lead from the US raises hopes of a recovery in the local bourse after yesterday's heavy sell off.

Market Wrap

AAP  |  FRIDAY, 14 OCT 2005
The Australian share market is expected to open weaker as a poor lead from offshore suggest further weakness for the local market heading into the end of the week.

Market wrap

AAP  |  THURSDAY, 13 OCT 2005
The Australian share market is expected to open sharply weaker as softer base and precious metal prices, combined with US markets retreating to the lowest level in around five months, paints a bleak picture for the local bourse.

Market wrap

AAP  |  WEDNESDAY, 12 OCT 2005
The Australian share market is expected to open firmer this morning as a recovery in commodity prices across the board should ensure the resource sector returns to the black.

Moderate growth outlook for US: Fidelity

The outlook for US economic growth is likely to be only moderate, but pockets of stronger growth may still be there for investors who know how to find it, says Fidelity.

Melbourne Biotech group wins Chinese investor

Melbourne's reputation as a biotech investment hub continues to grow with the recent awarding of a $3 million investment from a Chinese company to Melbourne based herbal medicine and therapeutic science group R&D.